Skip to main content
. 2006 Oct;12(10):1548–1558. doi: 10.3201/eid1210.051015

Figure 2.

Figure 2

Cost-effectiveness acceptability curves for inactivated influenza vaccine compared with no vaccination (A, children not a high risk; B, children at high risk). Cost-effective acceptability curves for live, attenuated vaccine compared with no vaccine (C, children not at high risk only). Box indicates the mean cost-effectiveness ratio.